Lymphoma Drugs Market Research Reports

Global B-cell Non Hodgkin Lymphoma Drugs Market 2018-2022 - Product Thumbnail Image

Global B-cell Non Hodgkin Lymphoma Drugs Market 2018-2022

  • Report
  • 107 Pages
From
Global Burkitt Lymphoma Therapeutics Market 2018-2022 - Product Thumbnail Image

Global Burkitt Lymphoma Therapeutics Market 2018-2022

  • Report
  • 109 Pages
From
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Global Lymphoma Partnering 2012 to 2018 - Product Thumbnail Image

Global Lymphoma Partnering 2012 to 2018

  • Report
  • 150 Pages
From
NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 - Product Thumbnail Image

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • Drug Pipelines
  • 162 Pages
From
NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 - Product Thumbnail Image

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • Drug Pipelines
  • 229 Pages
From
Market Spotlight: Waldenström Macroglobulinemia (WM) - Product Thumbnail Image

Market Spotlight: Waldenström Macroglobulinemia (WM)

  • Report
  • 32 Pages
From
NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034 - Product Thumbnail Image

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • Report
  • 196 Pages
From
Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027 - Product Thumbnail Image

Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027

  • Report
  • 92 Pages
From
Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026 - Product Thumbnail Image

Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

  • Report
  • 60 Pages
From
Non-Hodgkin Lymphoma - Heat Map and Analysis - Product Thumbnail Image

Non-Hodgkin Lymphoma - Heat Map and Analysis

  • Drug Pipelines
  • 15 Pages
From
CAS 23214-92-8 Adriamycin Chemical World Report - Product Thumbnail Image

CAS 23214-92-8 Adriamycin Chemical World Report

  • Report
  • 2153 Pages
CAS 4342-03-4 Dacarbazine Chemical World Report - Product Thumbnail Image

CAS 4342-03-4 Dacarbazine Chemical World Report

  • Report
  • 2141 Pages
CAS 936563-96-1 PCI-32765 Chemical World Report - Product Thumbnail Image

CAS 936563-96-1 PCI-32765 Chemical World Report

  • Report
  • 2069 Pages
Waldenstrom Macroglobulinemia R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Waldenstrom Macroglobulinemia R&D Pipeline Analysis Report, H2-2018

  • Report
  • 160 Pages
From
Anaplastic Large Cell Lymphoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 80 Pages
From
Indolent Lymphoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Indolent Lymphoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 170 Pages
From
Peripheral T Cell Lymphomas (PTCL) R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Peripheral T Cell Lymphomas (PTCL) R&D Pipeline Analysis Report, H2-2018

  • Report
  • 200 Pages
From
Burkitt Lymphoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Burkitt Lymphoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 100 Pages
From
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022 - Product Thumbnail Image

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022

  • Report
  • 230 Pages
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll